Surgical Science Sweden AB has the GF Score of 85, which implies that the company
might have
Good outperformance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Surgical Science Sweden AB
might have
Good outperformance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Surgical Science Sweden AB (FRA:4P41) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Surgical Science Sweden AB GF Score Related Terms
FRA:4P41 vs VEEV, BTSG, TEM: GF Score Comparison
For the Health Information Services subindustry, Surgical Science Sweden AB's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB GF Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's GF Score distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's GF Score falls into.
Surgical Science Sweden AB (FRA:4P41) has a GF Score of 85 as of Jul. 08, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Surgical Science Sweden AB and its competitors. This is near median its historical median of 82.00. Over the past decade, Surgical Science Sweden AB's GF Score has ranged from 28.00 to 94.00.
Is Surgical Science Sweden AB's GF Score too high?
Surgical Science Sweden AB's current GF Score of 85 is near median its 10-year median of 82.00. Over the past 10 years, this metric has ranged from a low of 28.00 to a high of 94.00. Overall, Surgical Science Sweden AB has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's GF Score compare to VEEV and BTSG?
Surgical Science Sweden AB's GF Score of 85 can be compared against companies in the Healthcare Providers & Services industry. Historically, Surgical Science Sweden AB's own GF Score has ranged from 28.00 to 94.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Healthcare Providers & Services company?
A good GF Score depends on the Healthcare Providers & Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Surgical Science Sweden AB and its competitors. Surgical Science Sweden AB's current GF Score is 85, which is near median its own 10-year median of 82.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (FRA:4P41) is currently considered Significantly Undervalued. The stock's GF Value™ is €13.90, compared to a current price of €2.86 — trading 79.5% below its estimated fair value. The current GF Score is 85, which is near median its 10-year median of 82.00. Surgical Science Sweden AB's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Surgical Science Sweden AB (FRA:4P41), the current GF Score is 85 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgical Science Sweden AB (FRA:4P41) Overvalued in 2026?
Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued.
The current stock price of €2.86 is trading 79.5% below its estimated GF Value™ of €13.90.
GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.
Key valuation signals for FRA:4P41:
GF Score: 85 (near median its 10-year median of 82.00)
GF Value™: €13.90 vs. price of €2.86 (79.5% below fair value)
No single metric tells the full story. See the FRA:4P41 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
85GF Score
Get the complete analysis for FRA:4P41
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4P41 has been successfully added to your 